RxDoctor Payments Data

Lauren Arias

Family · Fort Wayne, INNPI 1124802475

Payments from drug & device makers

$2,815in general payments, 2019–2025

Across 130 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$685
  • Vanda Pharmaceuticals Inc.$330
  • Bayer$223
  • AstraZeneca$184
  • Lilly USA, LLC$173
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$167
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$2,68195%
  • Education$1345%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,815 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin23$32,261
OzempicSemaglutide23$25,375
MounjaroTirzepatide11$11,538
Emgality PenGalcanezumab-Gnlm13$9,321
FarxigaDapagliflozin Propanediol13$8,668
SynthroidLevothyroxine Sodium17$963
Vilazodone Hcl12$812
Valsartan48$559
Testosterone Cypionate14$487
Duloxetine Hcl12$344
Gabapentin28$329
Vitamin D2Ergocalciferol (Vitamin D2)27$320
Ezetimibe21$303
Albuterol Sulfate HfaAlbuterol Sulfate15$291
Levocetirizine Dihydrochloride14$287

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$44$32,26123 claims
Novo NordiskOzempic$142$25,37523 claims
Lilly USA, LLCMounjaro$173$11,53811 claims
AstraZenecaFarxiga$184$8,66813 claims
AbbVieSynthroid$685$96317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.

Other family in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →